洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

【ChiCTR2500112339】The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

查看原文
立即下载
基本信息
登记号

ChiCTR2500112339

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-11-12

临床申请受理号

/

靶点

/

适应症

Obesity

试验通俗题目

The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

试验专业题目

The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1.To investigate whether the incorporation of ad-libitum intakes during dieting serves as a viable weight reduction strategy as compared to the traditional strategy of continuous energy restriction, thereby giving new insight in combating with the global obesity phenomenon; 2.To back up the proposed physiological and psychological benefits of ad-libitum intakes commonly used among the fitness communities with empirical evidence.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

The random number sequence will be generated by an independent statistician using a random number generator software to ensure an unbiased allocation with a 1:1:1 ratio across the groups

盲法

None

试验项目经费来源

The Education University of Hong Kong

试验范围

/

目标入组人数

25

实际入组人数

/

第一例入组时间

2025-11-13

试验终止时间

2026-03-31

是否属于一致性

/

入选标准

untrained obese (BMI >=25) female Chinese adults (age 18-35)；

排除标准

pregnancy, lactating women, history of eating disorders, psychological disorders, chronic diseases or other health problems that may affect participation; and are not involved in any dietary approaches for weight management in the past 12 months；

研究者信息
研究负责人姓名
请登录查看
试验机构

The Education University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Education University of Hong Kong的其他临床试验

更多

Department of Health and Physical Education, the Education University of Hong Kong的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品